{"id":134346,"date":"2022-10-04T10:00:00","date_gmt":"2022-10-04T14:00:00","guid":{"rendered":"https:\/\/hispanicprwire.com\/english-cancer-research-institutes-spanish-language-virtual-immunotherapy-patient-summit-now-available-on-demand-to-help-close-the-information-gap-for-hispanic-cancer-patients\/"},"modified":"2022-10-04T10:11:22","modified_gmt":"2022-10-04T14:11:22","slug":"la-conferencia-virtual-cri-de-inmunoterapia-para-pacientes-con-cancer-en-espanol-ahora-esta-disponible-en-linea-para-ayudar-a-igualar-el-acceso-a-la-informacion-para-los-pacientes-hispanos-con-cance","status":"publish","type":"post","link":"https:\/\/hispanicprwire.com\/en\/la-conferencia-virtual-cri-de-inmunoterapia-para-pacientes-con-cancer-en-espanol-ahora-esta-disponible-en-linea-para-ayudar-a-igualar-el-acceso-a-la-informacion-para-los-pacientes-hispanos-con-cance\/","title":{"rendered":"CANCER RESEARCH INSTITUTE&#8217;S SPANISH-LANGUAGE VIRTUAL IMMUNOTHERAPY PATIENT SUMMIT NOW AVAILABLE ON-DEMAND TO HELP CLOSE THE INFORMATION GAP FOR HISPANIC CANCER PATIENTS"},"content":{"rendered":"<p><\/p>\n<style type=\"text\/css\"><![CDATA[\n\/* Style Definitions *\/\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n]]><\/style>\n<div class=\"xn-content\">\n<p><i>The free event, moderated by Ana Patricia G\u00e1mez, shared the latest promising research by top immunotherapy experts, patient stories and clinical trial updates<\/i><\/p>\n<p><span class=\"xn-location\">NEW YORK<\/span>, <span class=\"xn-chron\">Oct. 4, 2022<\/span> \/PRNewswire-HISPANIC PR WIRE\/ &#8212; The Cancer Research Institute (CRI), a nonprofit organization spearheading transformative research in immunotherapy to control and potentially cure all cancers, continues its commitment to the U.S. Hispanic cancer community with on-demand free access to the 2022 CRI Virtual Immunotherapy Patient Summit in Spanish on <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3666551-1&amp;h=3103052691&amp;u=http%3A%2F%2Fcancerresearch.org%2Fconferencia&amp;a=cancerresearch.org%2Fconferencia\" target=\"_blank\" rel=\"nofollow\">cancerresearch.org\/conferencia<\/a>.<\/p>\n<div id=\"prni_dvprnevidcdd8left\" dir=\"ltr\" style=\"width: 100%; text-align: left;\" title=\"2022 CRI Virtual Immunotherapy Patient Summit in Spanish\"><iframe loading=\"lazy\" id=\"playerFrameVideo\" src=\"https:\/\/www.youtube.com\/embed\/rTnSB_aC0GQ?autoplay=0\" width=\"512\" height=\"288\" frameborder=\"0\" scrolling=\"auto\" data-poster=\"http:\/\/\" data-autostart=\"false\" data-mce-fragment=\"1\"\/><\/div>\n<p>Cancer immunotherapy uses the body&#8217;s own immune system to treat, control, and even eliminate cancer. The second annual <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3666551-1&amp;h=1793210009&amp;u=https%3A%2F%2Fwww.cancerresearch.org%2Fes%2Fconferencia&amp;a=CRI+Virtual+Immunotherapy+Patient+Summit+in+Spanish\" target=\"_blank\" rel=\"nofollow\">CRI Virtual Immunotherapy Patient Summit in Spanish<\/a> included the most up-to-date research from leading immunotherapy experts working in the field to help impact and improve cancer patient care. In fact, 97% of participants who responded to the post-event survey, found the summit to be very valuable and\/or valuable and felt that the explanations were easy to understand and very helpful.<\/p>\n<p>Moderated by Ana Patricia G\u00e1mez, TV host and entrepreneur, the Summit contained informative sessions and fireside chats with experts and doctors like Kurt Schalper, M.D., Ph.D., associate professor of pathology and medicine (Medical Oncology), <span class=\"xn-org\">Yale School of Medicine<\/span>, and director of the Translational Immuno-Oncology Laboratory, Yale Cancer Center. Panels led by Teresa Rodr\u00edguez, host of <i>Univisionarios<\/i> (Univision News)\u00a0and Carolina Sarassa, correspondent for <i>Aqu\u00ed y Ahora<\/i> and co-anchor of Univision&#8217;s noon newscast <i>Edici\u00f3n Digital<\/i> included the voices of leading experts like <span class=\"xn-person\">Antoni Ribas<\/span>, M.D., Ph.D., professor of medicine, surgery, and molecular and medical pharmacology at the <span class=\"xn-org\">University of California Los Angeles<\/span> (<span class=\"xn-org\">UCLA<\/span>), director of the Tumor Immunology Program at the Jonsson Comprehensive Cancer Center, and the chair of the Melanoma Committee at SWOG Cancer Research Network, speaking to the need for information and participation in clinical trials for a future immune to cancer for all patients.<\/p>\n<p>An early diagnosis can change a patient&#8217;s cancer journey and overall outcome. Unfortunately, Hispanic men and women are less likely to be diagnosed at an early stage. CRI is leading the charge to help close the immunotherapy information gap for the U.S. Hispanic cancer community by providing in-language research, information, and direct access to clinical trial consultations,\u00a0where a professional navigator will walk patients and their families through their immunotherapy clinical trial options.<\/p>\n<p>Support for the Spanish-language 2022 CRI Virtual Immunotherapy Patient Summit was generously provided by the following sponsors:<\/p>\n<p><b>Official Media Sponsor:\u00a0<\/b>TelevisaUnivision<\/p>\n<ul type=\"disc\">\n<li><b>Gold: <\/b><\/li>\n<ul type=\"disc\">\n<li>Bristol <span class=\"xn-person\">Myers Squibb<\/span><\/li>\n<\/ul>\n<li><b>Silver: <\/b><\/li>\n<ul type=\"disc\">\n<li>Merck &amp; Co., Inc.<\/li>\n<li>GSK<\/li>\n<\/ul>\n<li><b>Contributor:<\/b><\/li>\n<ul type=\"disc\">\n<li>Regeneron Pharmaceuticals, Inc.<\/li>\n<li>Sanofi<\/li>\n<\/ul>\n<li><b>Friend:<\/b><\/li>\n<ul type=\"disc\">\n<li>Eli Lilly and Company<\/li>\n<li>Genmab<\/li>\n<li>MorphoSys<\/li>\n<\/ul>\n<li><b>Host Institutions<\/b><\/li>\n<ul type=\"disc\">\n<li>Dana-Farber Cancer Institute<\/li>\n<li>NYU Langone Health<\/li>\n<li><span class=\"xn-org\">University of Chicago<\/span> Comprehensive Cancer Center<\/li>\n<li><span class=\"xn-org\">University of Texas<\/span> MD Anderson Cancer Center<\/li>\n<li>Yale Cancer Center and Smilow Cancer Hospital<\/li>\n<\/ul>\n<\/ul>\n<p>Visit <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3666551-1&amp;h=2606909433&amp;u=http%3A%2F%2Fwww.cancerresearch.org%2Fes&amp;a=cancerresearch.org%2Fes\" target=\"_blank\" rel=\"nofollow\">cancerresearch.org\/es<\/a> to see the robust and helpful offering of information now available in Spanish. Visit <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3666551-1&amp;h=199718153&amp;u=https%3A%2F%2Fwww.cancerresearch.org%2Fes%2Fconferencia&amp;a=cancerresearch.org%2Fes%2Fconferencia%C2%A0\" target=\"_blank\" rel=\"nofollow\">cancerresearch.org\/es\/conferencia\u00a0<\/a>to watch the free Spanish-language 2022 CRI Virtual Immunotherapy Patient Summit.<\/p>\n<p><b>About the Cancer Research Institute <br \/><\/b>The Cancer Research Institute (CRI), established in 1953, is a top\u2013rated U.S. nonprofit organization dedicated exclusively to saving more lives by fueling the discovery and development of powerful immunotherapies for all cancers. Guided by a world\u2013renowned Scientific Advisory Council that includes four Nobel laureates and 27 members of the National Academy of Sciences, CRI has invested <span class=\"xn-money\">$500 million<\/span> in support of research conducted by immunologists and tumor immunologists at the world&#8217;s leading medical centers and universities and has contributed to many of the key scientific advances that demonstrate the potential for immunotherapy to change the face of cancer treatment. To learn more, go to <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3666551-1&amp;h=2739642422&amp;u=https%3A%2F%2Fwww.cancerresearch.org%2Fes&amp;a=cancerresearch.org%2Fes\" target=\"_blank\" rel=\"nofollow\">cancerresearch.org\/es<\/a>.<\/p>\n<div id=\"prni_dvprnejpg7950left\" dir=\"ltr\" style=\"width: 100%; text-align: left;\"><img decoding=\"async\" id=\"prnejpg7950left\" title=\"Cancer Research Institute\" src=\"https:\/\/mma.prnewswire.com\/media\/1551076\/CRI_Logo.jpg\" alt=\"Cancer Research Institute\" align=\"middle\"\/><\/div>\n<p>Video &#8211; <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3666551-1&amp;h=4103882547&amp;u=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DrTnSB_aC0GQ&amp;a=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DrTnSB_aC0GQ\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.youtube.com\/watch?v=rTnSB_aC0GQ<\/a><\/p>\n<p>Photo &#8211; <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3666551-1&amp;h=2315957451&amp;u=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F1551076%2FCRI_Logo.jpg&amp;a=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F1551076%2FCRI_Logo.jpg\" target=\"_blank\" rel=\"nofollow\">https:\/\/mma.prnewswire.com\/media\/1551076\/CRI_Logo.jpg<\/a><\/p>\n<p>SOURCE  Cancer Research Institute<\/p>\n<\/div>\n<p><\/p>","protected":false},"excerpt":{"rendered":"<div class=\"xn-content\">\n<p><i>The free event, moderated by Ana Patricia G\u00e1mez, shared the latest promising research by top immunotherapy experts, patient stories and clinical trial updates<\/i><\/p>\n<p><span class=\"xn-location\">NEW YORK<\/span>, <span class=\"xn-chron\">Oct. 4, 2022<\/span> \/PRNewswire-HISPANIC PR WIRE\/ &#8212; The Cancer Research Institute (CRI), a nonprofit organization spearheading transformative research in immunotherapy to control and potentially cure all cancers, continues its commitment to the U.S. Hispanic cancer community with on-demand free access to the 2022 CRI Virtual&#8230;<\/p>\n","protected":false},"author":1,"featured_media":134347,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[13],"tags":[],"class_list":["post-134346","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-salud"],"acf":[],"_links":{"self":[{"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/posts\/134346","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/comments?post=134346"}],"version-history":[{"count":"1","href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/posts\/134346\/revisions"}],"predecessor-version":[{"id":134350,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/posts\/134346\/revisions\/134350"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/media\/134347"}],"wp:attachment":[{"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/media?parent=134346"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/categories?post=134346"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/tags?post=134346"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}